During the past decade, Advanced Clinical Research/Gut Whisperer conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Advanced Clinical Research/Gut Whisperer" are "Clostridium Difficile Infection" (1 trials), "NASH - Nonalcoholic Steatohepatitis" (1 trials) and "Nonalcoholic Steatohepatitis (NASH)" (1 trials). Many other conditions were trialed in "Advanced Clinical Research/Gut Whisperer" in a lesser frequency.

Most popular intervention types in "Advanced Clinical Research/Gut Whisperer" are "Drug" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Clostridium difficile vaccine" (1 trials), "LPCN 1144" (1 trials), "LPCN 1144 Formulation A" (1 trials) and "LPCN 1144 Formulation B" (1 trials). Other intervention names were less common.

The vast majority of trials in "Advanced Clinical Research/Gut Whisperer" are 2 trials for "Male" genders and 1 trials for "All" genders.

Currently, there are NaN active trials in "Advanced Clinical Research/Gut Whisperer". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Advanced Clinical Research/Gut Whisperer, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Advanced Clinical Research/Gut Whisperer, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".